Skip to content
value.today

Tallac Therapeutics, Inc.

Formerly Tollnine, Inc.

Total raised
$62 M
1 round on record
Latest round
$62 M
Jun 2020
First round on record
Jun 2020
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Tallac Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2020$62 MNo. 1$50 to $250 million

Tallac Therapeutics, Inc.: Raise no. 1, Jun 2020

Investors in this round

12 investors had bought by the notice of Jul 22, 2021: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$62 M of $62 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hong Wan · Executive Officer, Director
  • Christine Brennan · Director
  • Corey Goodman · Director
  • Isaac Cheng · Director
  • Jaume Pons · Director
  • Michael Carusi · Director
  • Ran Geng · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hong Wan, CEO & President. Newest notice filed Jul 22, 2021 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tallac Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2021).

    SEC Form D · Jul 2021

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2021

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tallac Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tallac Therapeutics, Inc.
NameRoleNamed in
Hong WanExecutive officerJul 2021
Christine BrennanDirectorJul 2021
Corey GoodmanDirectorJul 2021
Hong WanDirectorJul 2021
Isaac ChengDirectorJul 2021
Jaume PonsDirectorJul 2021
Michael CarusiDirectorJul 2021
Ran GengDirectorJul 2021